Clinical trial
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic…
NCT00359450 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00359450 |
|---|---|
| Title | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) |
| Official title | A Three Cohort Phase II Trial of BMS-275183 Given Orally on a Twice Weekly Schedule in Pretreated Locally Advanced or Metastatic NSCLC Patients |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | BMS-275183 (oral taxane) |
| Enrollment | 186 |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2007 |
| First posted | Aug 2, 2006 |
| Last update posted | Mar 2, 2010 |
| Countries | Belgium, Canada, France, Italy, Netherlands, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: